Literature DB >> 27843911

Immunoglobulin G4-Related Ophthalmic Disease Involving the Sclera Misdiagnosed as Intraocular Tumor: Report of One Case.

Hiroshi Goto1, Shunichiro Ueda1.   

Abstract

AIMS: Immunoglobulin G4 (IgG4)-related disease is known to have diverse clinical manifestations. We report a case of IgG4-related ophthalmic disease misdiagnosed as intraocular tumor.
METHODS: Case report.
RESULTS: A 41-year-old man was referred to our department with a diagnosis of intraocular tumor, presumably choroidal melanoma. Although MR imaging was compatible with choroidal melanoma, he had been observed periodically without treatment because fundus findings were not typical of melanoma and visual function was preserved. He was again referred to us 15 years later due to increased tumor size and visual field disturbance. Transscleral biopsy of the intraocular tumor was attempted to make a histopathological diagnosis. During the biopsy procedure, thick placoid tissue adhering to the sclera was found at a location consistent with the site of the elevated intraocular lesion. Histopathological examination of this extraocular material revealed proliferation of dense fibrous tissue with follicular proliferation of lymphocytes and plasmacytes. The plasmacytes were diffusely positive for IgG and IgG4. Serum IgG4 level was slightly elevated and no extraocular lesion was detected. Despite administration of systemic corticosteroids after biopsy, the intraocular mass was not reduced. Visual acuity of 20/20 has been maintained as of the last follow-up.
CONCLUSION: IgG4-related disease should be included in the differential diagnosis of intraocular elevated lesion.

Entities:  

Keywords:  Histopathology; Immunoglobulin G4-related ophthalmic disease; Intraocular tumor; Sclera; Transscleral biopsy

Year:  2016        PMID: 27843911      PMCID: PMC5091125          DOI: 10.1159/000447405

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  9 in total

1.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Tadashi Yoshino; Shigeo Nakamura; Shigeyuki Kawa; Hideaki Hamano; Terumi Kamisawa; Toru Shimosegawa; Akira Shimatsu; Seiji Nakamura; Tetsuhide Ito; Kenji Notohara; Takayuki Sumida; Yoshiya Tanaka; Tsuneyo Mimori; Tsutomu Chiba; Michiaki Mishima; Toshifumi Hibi; Hirohito Tsubouchi; Kazuo Inui; Hirotaka Ohara
Journal:  Mod Rheumatol       Date:  2012-01-05       Impact factor: 3.023

2.  Elevated IgG4 concentrations in serum of patients with Mikulicz's disease.

Authors:  M Yamamoto; M Ohara; C Suzuki; Y Naishiro; H Yamamoto; H Takahashi; K Imai
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

3.  IgG4-related disease involving the sclera.

Authors:  Kyotaro Ohno; Yasuharu Sato; Koh-Ichi Ohshima; Katsuyoshi Takata; Midori Ando; Lamia Abd Al-Kader; Noriko Iwaki; Mai Takeuchi; Yorihisa Orita; Tadashi Yoshino
Journal:  Mod Rheumatol       Date:  2014-01       Impact factor: 3.023

Review 4.  Diagnostic criteria for IgG4-related ophthalmic disease.

Authors:  Hiroshi Goto; Masayuki Takahira; Masahiro Takahira; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

Review 5.  International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.

Authors:  A Khosroshahi; Z S Wallace; J L Crowe; T Akamizu; A Azumi; M N Carruthers; S T Chari; E Della-Torre; L Frulloni; H Goto; P A Hart; T Kamisawa; S Kawa; M Kawano; M H Kim; Y Kodama; K Kubota; M M Lerch; M Löhr; Y Masaki; S Matsui; T Mimori; S Nakamura; T Nakazawa; H Ohara; K Okazaki; J H Ryu; T Saeki; N Schleinitz; A Shimatsu; T Shimosegawa; H Takahashi; M Takahira; A Tanaka; M Topazian; H Umehara; G J Webster; T E Witzig; M Yamamoto; W Zhang; T Chiba; J H Stone
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

6.  Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma.

Authors:  H Goto; M Usui; I Ishii
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

7.  Location and frequency of lesions in patients with IgG4-related ophthalmic diseases.

Authors:  Yuka Sogabe; Koh-ichi Ohshima; Atsushi Azumi; Masayuki Takahira; Satoru Kase; Hideki Tsuji; Hiroshi Yoshikawa; Tetsuya Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-03       Impact factor: 3.117

8.  IgG4-related Disease Masquerading as Recurrent Scleritis and Chronic Conjunctivitis.

Authors:  Elise Philippakis; Nathalie Cassoux; Frédéric Charlotte; Phuc LeHoang; Bahram Bodaghi; Coralie Bloch-Queyrat; Valérie Touitou
Journal:  Ocul Immunol Inflamm       Date:  2014-12-30       Impact factor: 3.070

9.  A prevalence study of IgG4-related ophthalmic disease in Japan.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2013-08-07       Impact factor: 2.447

  9 in total
  1 in total

1.  A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain.

Authors:  Giorgia Comai; Vania Cuna; Benedetta Fabbrizio; Elena Sabattini; Ornella Leone; Francesco Tondolo; Andrea Angeletti; Maria Cappuccilli; Rocco Liguori; Gaetano La Manna
Journal:  BMC Nephrol       Date:  2019-11-21       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.